ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAB1. A total of 18 filers reported holding ARRAY BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $17,596,000 | +44.6% | 10,000,000 | 0.0% | 0.95% | +76.5% |
| Q4 2018 | $12,170,000 | -3.4% | 10,000,000 | 0.0% | 0.54% | +104.6% |
| Q3 2018 | $12,604,000 | -6.4% | 10,000,000 | 0.0% | 0.26% | -47.8% |
| Q2 2018 | $13,464,000 | -49.6% | 10,000,000 | -50.0% | 0.50% | -29.7% |
| Q1 2018 | $26,726,000 | +136.0% | 20,000,000 | +100.0% | 0.71% | +142.0% |
| Q4 2017 | $11,326,000 | – | 10,000,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bluefin Trading, LLC | 426,050 | $129,484,000 | 18.33% |
| CSS LLC/IL | 20,740,000 | $63,098,000 | 3.63% |
| Weiss Asset Management LP | 10,225,000 | $31,105,000 | 1.89% |
| Redmile Group, LLC | 16,500,000 | $50,155,000 | 1.42% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,600,000 | $23,136,000 | 0.17% |
| LAZARD ASSET MANAGEMENT LLC | 10,690,000 | $32,542,000 | 0.05% |
| SG Americas Securities, LLC | 9,000 | $2,740,000 | 0.02% |
| DEUTSCHE BANK AG\ | 3,000,000 | $9,117,000 | 0.01% |
| Jefferies Group LLC | 230,000 | $699,000 | 0.01% |
| Citadel Advisors | 3,000,000 | $9,129,000 | 0.00% |